BioCentury | Aug 10, 2009
Financial News

XDx Inc completes venture financing

...Date completed: 8/5/09 Type: Venture financing Raised: $14.4 million Investors: Bristol-Myers Squibb; Burrill Venture Capital; Duff, Ackerman & Goodrich...
BioCentury | Oct 29, 2007
Finance

Ebb & Flow

Biogen Idec (BIIB) was off last week on slowing sales of Avonex interferon beta-1a, eroding $3.50 to $76.72 for the week. On the company's conference call, President and CEO James Mullen said 3Q07 sales of...
BioCentury | Sep 20, 2007
Financial News

Amyris raises $35 million

Amyris (Emeryville, Calif.) raised about $35 million in the first tranche of a $70 million series B round. The second tranche is expected to close by year end. Duff Ackerman & Goodrich Ventures led the...
BioCentury | Jan 6, 2006
Financial News

XDx raises $26.5 million

...XDx (South San Francisco, Calif.) raised $26.5 million in a series E round led by Duff, Ackerman & Goodrich...
Items per page:
1 - 4 of 4
BioCentury | Aug 10, 2009
Financial News

XDx Inc completes venture financing

...Date completed: 8/5/09 Type: Venture financing Raised: $14.4 million Investors: Bristol-Myers Squibb; Burrill Venture Capital; Duff, Ackerman & Goodrich...
BioCentury | Oct 29, 2007
Finance

Ebb & Flow

Biogen Idec (BIIB) was off last week on slowing sales of Avonex interferon beta-1a, eroding $3.50 to $76.72 for the week. On the company's conference call, President and CEO James Mullen said 3Q07 sales of...
BioCentury | Sep 20, 2007
Financial News

Amyris raises $35 million

Amyris (Emeryville, Calif.) raised about $35 million in the first tranche of a $70 million series B round. The second tranche is expected to close by year end. Duff Ackerman & Goodrich Ventures led the...
BioCentury | Jan 6, 2006
Financial News

XDx raises $26.5 million

...XDx (South San Francisco, Calif.) raised $26.5 million in a series E round led by Duff, Ackerman & Goodrich...
Items per page:
1 - 4 of 4